chr14-104709654-C-T
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_022489.4(INF2):c.2087C>T(p.Ala696Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,404 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A696G) has been classified as Uncertain significance.
Frequency
Consequence
NM_022489.4 missense
Scores
Clinical Significance
Conservation
Publications
- Charcot-Marie-Tooth disease dominant intermediate EInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet
- focal segmental glomerulosclerosis 5Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- familial idiopathic steroid-resistant nephrotic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_022489.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| INF2 | NM_022489.4 | MANE Select | c.2087C>T | p.Ala696Val | missense | Exon 12 of 23 | NP_071934.3 | ||
| INF2 | NM_001426862.1 | c.2087C>T | p.Ala696Val | missense | Exon 12 of 23 | NP_001413791.1 | |||
| INF2 | NM_001426863.1 | c.2087C>T | p.Ala696Val | missense | Exon 12 of 23 | NP_001413792.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| INF2 | ENST00000392634.9 | TSL:5 MANE Select | c.2087C>T | p.Ala696Val | missense | Exon 12 of 23 | ENSP00000376410.4 | ||
| INF2 | ENST00000617571.5 | TSL:1 | n.2087C>T | non_coding_transcript_exon | Exon 11 of 22 | ENSP00000483829.2 | |||
| INF2 | ENST00000675207.1 | c.2183C>T | p.Ala728Val | missense | Exon 12 of 23 | ENSP00000502644.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00000403 AC: 1AN: 248186 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460404Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 726494 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.2087C>T (p.A696V) alteration is located in exon 12 (coding exon 11) of the INF2 gene. This alteration results from a C to T substitution at nucleotide position 2087, causing the alanine (A) at amino acid position 696 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Focal segmental glomerulosclerosis 5;C4302667:Charcot-Marie-Tooth disease dominant intermediate E Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at